United Kingdom
University of Birmingham reports new Phase II trial of exenatide for IIH
The trial saw reductions in the number of headaches in participants across the 12-week period.
AstraZeneca and Daiichi Sankyo report positive data from trial of Enhertu
Cervical cancer trials decrease for 2022
Small Pharma’s depressive disorder therapy trial meets primary goal
MHRA authorises Decibel’s CTA for trial of DB-OTO in paediatric patients
Midatech Pharma to begin dose escalation Phase I study of MTX-110
BioNTech signs deal with UK government for personalised cancer therapies
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
